Patents

  1. Non-classical human leukocyte antigen binding object prediction method based on deep
    learning
    CN117393034A
  2. Protein-DNA interaction hot spot prediction method considering statistical preference and
    random grouping feature selection strategy
    CN117174176A
  3. Prediction method of binding site of RNA binding protein and circular RNA
    CN115881215A
  4. Long non-coding RNA recognition method based on CatBOost algorithm
    CN114822694A
  5. Identification method and system for plant salt and alkali resistance gene
    CN115295081A
  6. mRNA subcellular localization model training method, mRNA subcellular localization model localization method
    CN113837293A
  7. Potent and selective inhibitors of Nav1.7
    WO2022066767A2
  8. Peptides inhibiting covid-19
    WO2022233856A1
  9. Vaccine with reduced enhancement of viral infection
    US20170312354A1
  10. Prediction of unknown biological function of the active site in proteins or/and polynucleotides, and its utilization
    US20020098519A1
  11. Method of designing physiologically active peptide and use thereof
    CA2497477A1
  12. Normalization controls for managing low sample inputs in next generation sequencing
    EP3861135A1
  13. Universal influenza vaccine targeting virus/host recognition
    US20190351046A1
  14. Method of non-linear analysis of biological sequence data
    US6728642B2
  15. Peptide agonists of toll-like receptor 5 ligand and method of use
    US20170051021A1
  16. Method and electronic system for predicting at least one fitness value of a protein via an extended numerical sequence, related computer program product
    US20210265014A1
  17. Method of designing bioactive peptide and use thereof
    US7660677
  18. Analogous peptides of the internal image of a viral protein
    EP0728203A1
  19. Polypeptides mimicking the activity of human erythropoietin
    CA2258871A1
  20. Peptides which react with antibody representing the prognostic marker for HIV disease progression
    US20010007017A1
  21. Polypeptide immunologically cross-reactive with NTM peptide and with vasoactive intestinal peptide
    GB2313376A
  22. Vaccine with reduced enhancement of viral infection
    US10322171
  23. Peptides immunologically related to known viral protein
    US6294174
  24. Compositions and methods for flavivirus vaccination
    US10835596
  25. Computer aided drug resistance calculator calculating drug resistance using amprenavir as a case study
    US20150370964